VC-backed Tiburio Therapeutics appoints chief medical officer

Cambridge, Massachusetts-based Tiburio Therapeutics, a biopharmaceutical company launched by Cydan, has named Dr. Nerissa Kreher as chief medical officer. Previously, he worked at AVROBIO where he was chief medical officer. Tiburio is backed by New Enterprise Associates, Longitude Capital, Lundbeckfonden Ventures and Alexandria Venture Investments.

PeopleNorth AmericaUSHealthcareBriefs